Carrier Screening Market by Type (Expanded Carrier Screening, Targeted Disease Carrier Screening), by Technology (DNA Sequencing, Polymerase Chain Reaction, Microarrays, Others), by End User (Hospitals and clinics, Reference Laboratories, Physician Offices, Others) and Region, Global trends and forecast from 2022 to 2029

Published on: Oct 2023
From:USD $3499.00
Number Of Pages:125

Please Choose License Type

Single User

Team User

Corporate License

Request a Sample

INTERESTED IN THIS RESEARCH?

Contact our analysts for inquiries, samples, and expert insights.

Market Size	CAGR	Dominating Region
USD 5.06 billion by 2029	13.8%	North America

by Type	by Technology	by End User
Expanded Carrier Screening Targeted Disease Carrier Screening	DNA Sequencing Polymerase Chain Reaction Microarrays Others	Hospitals and Clinics Reference Laboratories Physician Offices Others

5/5 - (4 votes)

Carrier Screening Market Overview

The carrier screening market is expected to grow at 13.8% CAGR from 2022 to 2029. It is expected to reach above USD 5.06 billion by 2029 from USD 1.58 billion in 2020.

Using a genetic test called carrier screening, it is possible to determine whether a person carries the gene responsible for a particular genetic disorder. We can use it to determine whether a test is administered prior to or during pregnancy to learn the likelihood that a kid will be born with a genetic condition. Blood, saliva, or tissue from the inside of the cheek are tested as part of the carrier screening process. When a test is negative, it signifies that a person does not have the gene; when a test is positive, it means that a person has. Usually, the partner with the highest likelihood of carrying the infection is tested first. There is no need for additional testing if test results indicate that the initial partner is not a carrier. Due to many genetic disease incidences, which presents a market potential for carrier screening, the diagnostic and biotechnology industries have experienced growth and innovation.

Carrier Screening Market | Exactitude Consultancy

Increased use of cutting-edge technology in new tests being introduced by major players around the world is expected to have a positive impact on market expansion. With the use of the brand-new QIAseq Expanded Carrier Screening Panel, more than 200 illness indicators can be linked to specific targets, genes, and other regions of interest. The high potential for technology adoption in developing nations as a result of an increase in the prevalence of genetic disorders, a rise in the use of practices to identify people who are genetic carriers, and a rise in the demand for carrier screening is also anticipated to be a major factor in the market share growth for carrier screening. Additionally, the healthcare sector in emerging economies is expanding at a significant rate as a result of the rise in demand for improved diagnostics technologies, sizeable investments made by the government to advance diagnostic testing, and the establishment of robust biotechnological industries in emerging nations. Additionally, the adoption of the tests may be influenced by how cost-effective the carrier screening tests are. The population’s ethical reservations regarding carrier screening, however, and the strict laws governing the clearance of carrier screening tests are impeding market expansion.

In order to get a relevant result, it may be required to do more than one test or test several members of the same family. For neonatal screening, this price may differ by state. Though most states impose a fee per infant, some states partially cover the overall expense. In order to further assist market expansion, the cost-effectiveness of carrier screening is credited. Developing nations like China, Brazil, and India are also experiencing a rise in the demand for carrier screening, which is boosting the market’s expansion. This demand is not just present in developed nations. The market is expanding as a result of additional factors like a rise in the use of genetic screening among couples and an increase in awareness of the danger of genetic diseases. The use of carrier screening is also encouraged by an increase in consumer awareness of infant preventative healthcare. In addition, manufacturers’ increased research efforts to create creative carrier screening technology solutions are anticipated to accelerate their uptake soon.

The carrier screening market continues to experience a negative overall COVID-19 impact. A decrease in the number of patients seeking genetic counselling as a result of the interrupted healthcare services, including genetic counselling, led to a scarcity of workers to carry out the vital tasks needed by newborn screening (NBS) programmes. For carrier screening, the post-COVID scenario has changed. The telehealth consultancy programmed is growing more popular. Additionally, prior to the COVID?19 pandemic, clinic employees and phlebotomy technicians took samples right after the genetic counselling session. However, patients now have the choice of visiting an independent phlebotomy clinic or choosing mobile phlebotomy services through the genetic testing laboratory thanks to the implementation of direct-to-patient (D2P) telehealth visits as a result of COVID-19.

ATTRIBUTE	DETAILS
Study period	2020-2029
Base year	2021
Estimated year	2022
Forecasted year	2022-2029
Historical period	2018-2020
Unit	Value (USD Billion)
Segmentation	By Type, By Technology, By End User, By Region
By Type	Expanded Carrier Screening Targeted Disease Carrier Screening
By Technology	DNA Sequencing Polymerase Chain Reaction Microarrays Others
By End User	Hospitals and clinics Reference Laboratories Physician Offices Others
By Region	North America Asia Pacific Europe South America Middle East Asia & Africa

Carrier Screening Market Segment Analysis

The carrier screening market is segmented based on type, technology, end user, and region.

By type the market is segmented into expanded carrier screening, targeted disease carrier screening. A significant portion of the market made up of expanded carrier screening. Expanded carrier screening is a form of carrier screening that examines more genetic disorders than conventional carrier screening, including some uncommon and less well-known ones. Individuals and couples thinking about family planning can get more thorough information from expanded carrier screening.

By technology the market is segmented into DNA sequencing, polymerase chain reaction, microarrays, others. A significant portion of the market made up of DNA sequencing. Due to advancements in genetic analysis methods, including tests based on next-generation sequencing and microarray technology, molecular diagnostics, and improving the type for hereditary disorders, it is anticipated that this market will continue to dominate in the anticipated time period.

By end user the market is segmented into hospitals and clinics, reference laboratories, physician offices, others. A significant portion of the market made up of hospitals and clinics. The increase in the number of patients, the increase in Medicare reimbursement for clinical tests performed in hospitals, and the introduction of new diagnostic tests are some of the major factors influencing the growth of this end-user market.

Carrier Screening Market Key Players

The carrier screening market key players include Bio-Techne, Invitae, Fulgent Genetics, Illumina, Sema4, Natera Inc., LabCorp, CENTOGENE, Thermo Fisher Scientific, Myriad Genetics.

Recent News:

On December 2022, Asuragen, a Bio-Techne brand (NASDAQ: TECH) and Oxford Nanopore Technologies plc (Oxford Nanopore) (LSE: ONT), announced a collaboration to develop assays designed to deliver more accurate and reliable options for reproductive health and carrier screening. Asuragen will leverage its gold-standard PCR technology with Oxford Nanopore’s any-read-length DNA sequencing capabilities to developed the first sequencing system to identify the most challenging yet high prevalence carrier genes in a single, unified workstream that required multiple other methods.
On April 2023, Invitae(NYSE: NVTA), a leading medical genetics company, announced new research published in Nature describing the first use of the company’s personalized cancer monitoring (PCM) platform to demonstrated the utility of ctDNA as a biomarker for cancer recurrence in a large cohort of patients with stage I-III non-small-cell lung cancer (NSCLC) followed for up to five years.

Who Should Buy? Or Key Stakeholders

Healthcare Industry
Hospitals and Clinics
Scientific Research and Development
Investors
Manufacturing Companies
End User Companies
Government and Regulatory Authorities
Others

Carrier Screening Market Regional Analysis

The carrier screening market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).

North America: includes the US, Canada, Mexico, and Rest of North America
Asia Pacific: includes China, Japan, South Korea, India, Australia, and Rest of APAC
Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
South America: includes Brazil, Argentina, and Rest of South America
Middle East & Africa: includes UAE, South Africa, Saudi Arabia, and Rest of MEA

In 2021, North America had a market share of more than 43%, the large share of North America can be attributed to a number of things, including the presence of well-established healthcare systems in the US and Canada, widespread access to advanced screening techniques (like DNA sequencing), recommendations for carrier screening, a high and growing demand for the early detection of genetic disorders among the population, the availability of mass genetic testing programmes, an increase in awareness campaigns, and the high incidence of chromo.

Key Market Segments: Carrier Screening Market

Carrier Screening Market by Type, 2020-2029, (USD Billion)

Expanded Carrier Screening
Targeted Disease Carrier Screening

Carrier Screening Market by Technology, 2020-2029, (USD Billion)

DNA Sequencing
Polymerase Chain Reaction
Microarrays
Others

Carrier Screening Market by End User, 2020-2029, (USD Billion)

Hospitals and Clinics
Reference Laboratories
Physician Offices
Others

Carrier Screening Market by Region, 2020-2029, (USD Billion)

North America
Asia Pacific
Europe
South America
Middle East and Africa

Important Countries in All Regions Are Covered.

Key Question Answered

What is the expected growth rate of the carrier screening market over the next 7 years?
Who are the major players in the carrier screening market and what is their market share?
What are the end user industries driving demand for market and what is their outlook?
What are the opportunities for growth in emerging markets such as Asia-Pacific, Middle East, and Africa?
How is the economic environment affecting the carrier screening market, including factors such as interest rates, inflation, and exchange rates?
What is the expected impact of government policies and regulations on the carrier screening market?
What is the current and forecasted size and growth rate of the global carrier screening market?
What are the key drivers of growth in the carrier screening market?
Who are the major players in the market and what is their market share?
What are the distribution channels and supply chain dynamics in the carrier screening market?
What are the technological advancements and innovations in the carrier screening market and their impact on product development and growth?
What are the regulatory considerations and their impact on the market?
What are the challenges faced by players in the carrier screening market and how are they addressing these challenges?
What are the opportunities for growth and expansion in the carrier screening market?
What are the product offerings and specifications of leading players in the market?
What is the pricing trend of carrier screening market in the market and what is the impact of raw material prices on the price trend?

Exactitude Consultancy Services Key Objectives:

Increasing sales and market share
Developing new technology
Improving profitability
Entering new markets
Enhancing brand reputation

INTRODUCTION
1. MARKET DEFINITION
2. MARKET SEGMENTATION
3. RESEARCH TIMELINES
4. ASSUMPTIONS AND LIMITATIONS
RESEARCH METHODOLOGY
1. DATA MINING
  1. SECONDARY RESEARCH
  2. PRIMARY RESEARCH
  3. SUBJECT-MATTER EXPERTS’ ADVICE
2. QUALITY CHECKS
  1. FINAL REVIEW
3. DATA TRIANGULATION
  1. BOTTOM-UP APPROACH
  2. TOP-DOWN APPROACH
  3. RESEARCH FLOW
4. DATA SOURCES
EXECUTIVE SUMMARY
MARKET OVERVIEW
1. GLOBAL CARRIER SCREENING MARKET OUTLOOK
  1. MARKET DRIVERS
  2. MARKET RESTRAINTS
  3. MARKET OPPORTUNITIES
2. IMPACT OF COVID-19 ON CARRIER SCREENING MARKET
3. PORTER’S FIVE FORCES MODEL
  1. THREAT FROM NEW ENTRANTS
  2. THREAT FROM SUBSTITUTES
  3. BARGAINING POWER OF SUPPLIERS
  4. BARGAINING POWER OF CUSTOMERS
  5. DEGREE OF COMPETITION
4. INDUSTRY VALUE CHAIN ANALYSIS
GLOBAL CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029
1. EXPANDED CARRIER SCREENING
2. TARGETED DISEASE CARRIER SCREENING
GLOBAL CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
1. DNA SEQUENCING
2. POLYMERASE CHAIN REACTION
3. MICROARRAYS
4. OTHERS
GLOBAL CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029
1. HOSPITALS AND CLINICS
2. REFERENCE LABORATORIES
3. PHYSICIAN OFFICES
4. OTHERS
GLOBAL CARRIER SCREENING MARKET BY REGION (USD BILLION), 2020-2029
1. NORTH AMERICA
  1. US
  2. CANADA
  3. MEXICO
2. SOUTH AMERICA
  1. BRAZIL
  2. ARGENTINA
  3. COLOMBIA
  4. REST OF SOUTH AMERICA
3. EUROPE
  1. GERMANY
  2. UK
  3. FRANCE
  4. ITALY
  5. SPAIN
  6. RUSSIA
  7. REST OF EUROPE
4. ASIA PACIFIC
  1. INDIA
  2. CHINA
  3. JAPAN
  4. SOUTH KOREA
  5. AUSTRALIA
  6. REST OF ASIA PACIFIC
5. MIDDLE EAST AND AFRICA
  1. UAE
  2. SAUDI ARABIA
  3. SOUTH AFRICA
  4. REST OF MIDDLE EAST AND AFRICA

COMPANY PROFILES* (BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)

BIO-TECHNE
INVITAE
FULGENT GENETICS
ILLUMINA
SEMA4
NATERA INC.
LABCORP
CENTOGENE
THERMO FISHER SCIENTIFIC
MYRIAD GENETICS. *THE COMPANY LIST IS INDICATIVE

LIST OF TABLES

TABLE 1 GLOBAL CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 2 GLOBAL CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 3 GLOBAL CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 4 GLOBAL CARRIER SCREENING MARKET BY REGION (USD BILLION), 2020-2029

TABLE 5 NORTH AMERICA CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 6 NORTH AMERICA CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 7 NORTH AMERICA CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 8 NORTH AMERICA CARRIER SCREENING MARKET BY COUNTRY (USD BILLION), 2020-2029

TABLE 9 US CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 10 US CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 11 US CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 12 CANADA CARRIER SCREENING MARKET BY TYPE (BILLION), 2020-2029

TABLE 13 CANADA CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 14 CANADA CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 15 MEXICO CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 16 MEXICO CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 17 MEXICO CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 18 REST OF NORTH AMERICA CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 19 REST OF NORTH AMERICA CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 20 REST OF NORTH AMERICA CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 21 SOUTH AMERICA CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 22 SOUTH AMERICA CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 23 SOUTH AMERICA CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 24 SOUTH AMERICA CARRIER SCREENING MARKET BY COUNTRY (USD BILLION), 2020-2029

TABLE 25 BRAZIL CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 26 BRAZIL CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 27 BRAZIL CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 28 ARGENTINA CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 29 ARGENTINA CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 30 ARGENTINA CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 31 COLOMBIA CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 32 COLOMBIA CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 33 COLOMBIA CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 34 REST OF SOUTH AMERICA CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 35 REST OF SOUTH AMERICA CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 36 REST OF SOUTH AMERICA CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 37 ASIA-PACIFIC CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 38 ASIA-PACIFIC CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 39 ASIA-PACIFIC CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 40 ASIA-PACIFIC CARRIER SCREENING MARKET BY COUNTRY (USD BILLION), 2020-2029

TABLE 41 INDIA CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 42 INDIA CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 43 INDIA CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 44 CHINA CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 45 CHINA CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 46 CHINA CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 47 JAPAN CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 48 JAPAN CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 49 JAPAN CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 50 SOUTH KOREA CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 51 SOUTH KOREA CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 52 SOUTH KOREA CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 53 AUSTRALIA CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 54 AUSTRALIA CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 55 AUSTRALIA CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 56 REST OF ASIA PACIFIC CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 57 REST OF ASIA PACIFIC CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 58 REST OF ASIA PACIFIC CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 59 EUROPE CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 60 EUROPE CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 61 EUROPE CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 62 EUROPE CARRIER SCREENING MARKET BY COUNTRY (USD BILLION), 2020-2029

TABLE 63 GERMANY CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 64 GERMANY CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 65 GERMANY CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 66 UK CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 67 UK CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 68 UK CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 69 FRANCE CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 70 FRANCE CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 71 FRANCE CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 72 ITALY CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 73 ITALY CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 74 ITALY CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 75 SPAIN CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 76 SPAIN CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 77 SPAIN CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 78 RUSSIA CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 79 RUSSIA CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 80 RUSSIA CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 81 REST OF EUROPE CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 82 REST OF EUROPE CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 83 REST OF EUROPE CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 84 MIDDLE EAST AND AFRICA CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 85 MIDDLE EAST AND AFRICA CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 86 MIDDLE EAST AND AFRICA CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 87 MIDDLE EAST AND AFRICA CARRIER SCREENING MARKET BY COUNTRY (USD BILLION), 2020-2029

TABLE 88 UAE CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 89 UAE CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 90 UAE CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 91 SAUDI ARABIA CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 92 SAUDI ARABIA CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 93 SAUDI ARABIA CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 94 SOUTH AFRICA CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 95 SOUTH AFRICA CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 96 SOUTH AFRICA CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

TABLE 97 REST OF MIDDLE EAST AND AFRICA CARRIER SCREENING MARKET BY TYPE (USD BILLION), 2020-2029

TABLE 98 REST OF MIDDLE EAST AND AFRICA CARRIER SCREENING MARKET BY TECHNOLOGY (USD BILLION), 2020-2029

TABLE 99 REST OF MIDDLE EAST AND AFRICA CARRIER SCREENING MARKET BY END USER (USD BILLION), 2020-2029

LIST OF FIGURES

FIGURE 1 MARKET DYNAMICS

FIGURE 2 MARKET SEGMENTATION

FIGURE 3 REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4 DATA TRIANGULATION

FIGURE 5 BOTTOM-UP APPROACH

FIGURE 6 TOP-DOWN APPROACH

FIGURE 7 RESEARCH FLOW

FIGURE 8 GLOBAL CARRIER SCREENING MARKET BY TYPE, USD BILLION, 2020-2029

FIGURE 9 GLOBAL CARRIER SCREENING MARKET BY TECHNOLOGY, USD BILLION, 2020-2029

FIGURE 10 GLOBAL CARRIER SCREENING MARKET BY END USER, USD BILLION, 2020-2029

FIGURE 11 GLOBAL CARRIER SCREENING MARKET BY REGION, USD BILLION, 2020-2029

FIGURE 12 PORTER’S FIVE FORCES MODEL

FIGURE 13 CARRIER SCREENING MARKET BY REGION 2021

FIGURE 14 CARRIER SCREENING MARKET BY TYPE 2021

FIGURE 15 CARRIER SCREENING MARKET BY TECHNOLOGY 2021

FIGURE 16 CARRIER SCREENING MARKET BY END USER 2021

FIGURE 17 MARKET SHARE ANALYSIS

FIGURE 18 BIO-TECHNE: COMPANY SNAPSHOT

FIGURE 19 INVITAE: COMPANY SNAPSHOT

FIGURE 20 FULGENT GENETICS: COMPANY SNAPSHOT

FIGURE 21 ILLUMINA: COMPANY SNAPSHOT

FIGURE 22 SEMA4: COMPANY SNAPSHOT

FIGURE 23 NATERA INC.: COMPANY SNAPSHOT

FIGURE 24 LABCORP: COMPANY SNAPSHOT

FIGURE 25 CENTOGENE: COMPANY SNAPSHOT

FIGURE 26 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT

FIGURE 27 MYRIAD GENETICS: COMPANY SNAPSHOT

• What is the expected CAGR in terms of revenue for the global carrier screening market over the forecast period (2020–2029)?

The global carrier screening market revenue is projected to expand at a CAGR of 13.8% during the forecast period.

• What was the global carrier screening market valued at in 2020?

The global carrier screening market was valued at USD 1.58 Billion in 2020.

• Who are the key players in the carrier screening market?

The carrier screening market key players include Bio-Techne, Invitae, Fulgent Genetics, Illumina, Sema4, Natera Inc., LabCorp, CENTOGENE, Thermo Fisher Scientific, Myriad Genetics.

• What are the factors driving the carrier screening market?

The probability of fatal chromosomal abnormalities is closely correlated with the ageing of the mother. This increase in average maternal age is probably going to increase the prevalence of chromosomal disorders, which will raise need for carrier screening.

• What are the different segments of the global carrier screening market?

The global carrier screening market is divided into type, technology, end user, and region.

• Which region will lead the global carrier screening market?

The region that contributed the most to the market in 2021 and is expected to continue to do so in the future is North America. This can be attributed to the frequent testing that is done to find out if a person is at risk or a carrier of any genetic disorders. The market is further supported by the highly developed healthcare system and a few well-established competitors.

In-Depth Database

Our Report’s database covers almost all topics of all regions over the Globe.

Recognised Publishing Sources

Tie ups with top publishers around the globe.

Customer Support

Complete pre and post sales
support.

Safe & Secure

Complete secure payment
process.

INTERESTED IN THIS RESEARCH?

REPORT OUTLOOK

SCOPE OF THE REPORT